BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 21187373)

  • 1. Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation.
    De Maria A; Bozzano F; Cantoni C; Moretta L
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):728-32. PubMed ID: 21187373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status.
    Chalan P; Bijzet J; Kroesen BJ; Boots AM; Brouwer E
    J Rheumatol; 2016 Jun; 43(6):1008-16. PubMed ID: 27036380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells.
    Cooper MA; Fehniger TA; Ponnappan A; Mehta V; Wewers MD; Caligiuri MA
    Eur J Immunol; 2001 Mar; 31(3):792-801. PubMed ID: 11241284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD16- CD56+ natural killer cells after bone marrow transplantation.
    Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE
    Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.
    Domaica CI; Fuertes MB; Uriarte I; Girart MV; Sardañons J; Comas DI; Di Giovanni D; Gaillard MI; Bezrodnik L; Zwirner NW
    PLoS One; 2012; 7(12):e51677. PubMed ID: 23240056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential IFN-γ production by adult and neonatal blood CD56+ natural killer (NK) and NK-like-T cells in response to Trypanosoma cruzi and IL-15.
    Guilmot A; Carlier Y; Truyens C
    Parasite Immunol; 2014 Jan; 36(1):43-52. PubMed ID: 24102464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
    Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
    Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset.
    Hayhoe RP; Henson SM; Akbar AN; Palmer DB
    Hum Immunol; 2010 Jul; 71(7):676-81. PubMed ID: 20394788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD56
    Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
    Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
    Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
    J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs.
    Fan YY; Yang BY; Wu CY
    Cell Biol Int; 2008 Feb; 32(2):188-97. PubMed ID: 17920947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.
    He XS; Draghi M; Mahmood K; Holmes TH; Kemble GW; Dekker CL; Arvin AM; Parham P; Greenberg HB
    J Clin Invest; 2004 Dec; 114(12):1812-9. PubMed ID: 15599406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56
    Lajoie L; Congy-Jolivet N; Bolzec A; Thibault G
    Front Immunol; 2017; 8():1556. PubMed ID: 29209315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation status of CD56
    Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immature and activated phenotype of blood NK cells is associated with acute rejection in adult liver transplant.
    Song S; Zhi Y; Tian G; Sun X; Chen Y; Qiu W; Jiao W; Huang H; Yu Y; Li M; Lv G
    Liver Transpl; 2023 Aug; 29(8):836-848. PubMed ID: 37002601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56
    Veneziani I; Alicata C; Pelosi A; Landolina N; Ricci B; D'Oria V; Fagotti A; Scambia G; Moretta L; Maggi E
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
    Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
    Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.
    Dulphy N; Haas P; Busson M; Belhadj S; Peffault de Latour R; Robin M; Carmagnat M; Loiseau P; Tamouza R; Scieux C; Rabian C; Di Santo JP; Charron D; Janin A; Socié G; Toubert A
    J Immunol; 2008 Aug; 181(3):2227-37. PubMed ID: 18641363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.